MEDI-1191

N/A

Report date: 2026/04/13 20:02:18

Base Information

Drug NameMEDI-1191
Drug Alias NamemRNA encoding IL-12MEDI1191MEDI-1191
ClassificationCell and gene therapy > Gene therapy > mRNACell and gene therapy > Gene therapy > LNP
Mechanisms of ActionInterleukin-12 stimulants
TargetsInterleukin-12
Therapy Area/IndicationsSolid tumoursNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesSpain
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesModerna Inc
China Registration ClassN/A

Develop Information

Active CompaniesMedimmune Llc
Inactive CompaniesN/A
Active IndicationsSolid tumours
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A